Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.51 |
| ▸ | PPARA | Q07869 | 5/20 | 0.51 |
| ▸ | CNR1 | P21554 | 1/20 | 0.51 |
| ▸ | CNR2 | P34972 | 1/20 | 0.51 |
| ▸ | TERT | O14746 | 3/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | PPARD | Q03181 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | FAAH | O00519 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5452957 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL864034 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL3710792 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL11743976 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL14672999 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL874683 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL347470 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL22555434 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL22555479 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL7902650 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024014801-A1 | METHOD FOR PREPARING SAPIENIC ACID, TRANS-ISOMER THEREOF, AND SAPIENIC ACID ESTER | 전종열 | 2024-01-18 | — | — | WO | claimed |
| WO-2026085609-A1 | METHODS FOR PRODUCING POLYUNSATURATED FATTY ACIDS FROM AQUACULTURE RESIDUES | LES LABORATOIRES ISO-BIOKEM INC. (CA) | 2026-04-30 | — | — | WO | disclosed |
| US-20240084343-A1 | METHODS OF USING NATURAL AND ENGINEERED ORGANISMS TO PRODUCE SMALL MOLECULES FOR INDUSTRIAL APPLICATION | KIVERDI INC (US) | 2024-03-14 | — | — | US | disclosed |
| WO-2024014801-A1 | METHOD FOR PREPARING SAPIENIC ACID, TRANS-ISOMER THEREOF, AND SAPIENIC ACID ESTER | 전종열 | 2024-01-18 | — | — | WO | disclosed |
| US-8361922-B2 | Organometallic ruthenium complexes and related methods for the preparation of tetra-substituted and other hindered olefins | MATERIA, INC. (US) | 2013-01-29 | — | — | US | disclosed |
| US-20120123133-A1 | ORGANOMETALLIC RUTHENIUM COMPLEXES AND RELATED METHODS FOR THE PREPARATION OF TETRA-SUBSTITUTED AND OTHER HINDERED OLEFINS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2012-05-17 | — | — | US | disclosed |
| US-8008224-B2 | Organometallic ruthenium complexes and related methods for the preparation of tetra-substituted and other hindered olefins | MATERIA, INC. (US) | 2011-08-30 | — | — | US | disclosed |
| US-20070282148-A1 | Organometallic ruthenium complexes and related methods for the preparation of tetra-substituted and other hindered olefins | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2007-12-06 | — | — | US | disclosed |
| EP-0910561-B1 | INHIBITORS OF OLEAMIDE HYDROLASE | SCRIPPS RESEARCH INST (US) | 2004-04-07 | — | — | EP | disclosed |
| US-6096784-A | Inhibitors of oleamide hydrolase | THE SCRIPPS RESEARCH INSTITUTE (US) | 2000-08-01 | — | — | US | disclosed |
| US-5856537-A | Inhibitors of oleamide hydrolase | THE SCRIPPS RESEARCH INSTITUTE (US) | 1999-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120123133-A1 | ORGANOMETALLIC RUTHENIUM COMPLEXES AND RELATED METHODS FOR THE PREPARATION OF TETRA-SUBSTITUTED AND OTHER HINDERED OLEFINS | ORC3, OXER1, CBR3 | PPARG 3385/4885PPARA 3718/4885CNR1 542/4885 |
| US-20070282148-A1 | Organometallic ruthenium complexes and related methods for the preparation of tetra-substituted and other hindered olefins | ORC3, OXER1, CBR3 | PPARG 3385/4885PPARA 3718/4885CNR1 542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.